Michael Zinda

CIK 1815366 · EVP, CHIEF SCIENTIFIC OFFICER · last filed 2025-03-14

Michael Zinda is an EVP, CHIEF SCIENTIFIC OFFICER who has filed 20 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing shows the insider sold $6.4K of RPTX on Mar 14, 2025. Across all open-market trades the lifetime net is −$6.7M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

20

Lifetime Open-Market Net

-$6.67M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Repare Therapeutics Inc. (RPTX) Delisted EVP, CHIEF SCIENTIFIC OFFICER 80,297 $2.65 $212.8K -$6.67M 20 2025-03-14

Recent Filings

20 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-03-14 Repare Therapeutics Inc. (RPTX) Delisted Sell (S) −5,611 -$6.4K EDGAR
2025-03-06 Repare Therapeutics Inc. (RPTX) Delisted Grant (A) +14,000 $0 EDGAR
2024-04-01 Repare Therapeutics Inc. (RPTX) Delisted Sell (S) −860 -$4.0K EDGAR
2024-03-27 Repare Therapeutics Inc. (RPTX) Delisted Sell (S) −1,350 -$6.3K EDGAR
2024-03-04 Repare Therapeutics Inc. (RPTX) Delisted Grant (A) +14,000 $0 EDGAR
2023-06-09 Repare Therapeutics Inc. (RPTX) Delisted Sell (S) −3,535 -$42.6K EDGAR
2023-06-07 Repare Therapeutics Inc. (RPTX) Delisted Sell (S) −1,200 -$14.4K EDGAR
2023-02-01 Repare Therapeutics Inc. (RPTX) Delisted Grant (A) +24,550 $0 EDGAR
2022-03-16 Repare Therapeutics Inc. (RPTX) Delisted Sell (S) −533 -$6.0K EDGAR
2022-01-20 Repare Therapeutics Inc. (RPTX) Delisted Exer (M) $0 EDGAR
Showing 110 of 20
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.